Paper 11 - A PHASE II, SINGLE ARM STUDY OF AVELUMAB IN COMBINATION WITH AXITINIB IN PATIENTS WITH UNRESECTABLE/METASTATIC GASTROINTESTINAL STROMAL TUMOR AFTER FAILURE OF STANDARD THERAPY (AXAGIST)

Author(s)

• 

  Katarzyna Kozak, MD PhD

  medical oncologist
  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland

  Slides

Co-Author(s)

• AK

  Anna Klimczak, MD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• PT

  Pawel Teterycz, MD, PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• TS

  Tomasz Switaj, MD PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• PR

  Pawel Rogala, MD PhD

  Maria Sklodowska-Curie National Research Institute of Oncology
  Warsaw, Mazowieckie, Poland
• MP

  Maria Abbondanza Pantaleo, MD

  Università di Bologna
  Bologns, Emilia-Romagna, Italy
• PR

  Piotr Ł. Rutkowski, Professor, MD, PhD

  Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw Poland
  Warsaw, Mazowieckie, Poland